1. FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma. Issue 2 (14th February 2021) Authors: Wang, Siwei; Han, Chencheng; Liu, Tongyan; Ma, Zhifei; Qiu, Mantang; Wang, Jie; You, Qingjun; Zheng, Xiufen; Xu, Weizhang; Xia, Wenjia; Xu, Youtao; Hu, Jingwen; Xu, Lin; Yin, Rong Journal: Clinical and translational medicine Issue: Volume 11:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer. Issue 1 (19th November 2019) Authors: Liu, Tongyan; Fang, Panqi; Han, Chencheng; Ma, Zhifei; Xu, Weizhang; Xia, Wenjia; Hu, Jingwen; Xu, Youtao; Xu, Lin; Yin, Rong; Wang, Siwei; Zhang, Qin Journal: Journal of cellular and molecular medicine Issue: Volume 24:Issue 1(2020) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma. Issue 7 (9th June 2021) Authors: Fang, Panqi; Chen, Hao; Ma, Zhifei; Han, Chencheng; Yin, Wenda; Wang, Siwei; Zhu, Hongyu; Xia, Wenjia; Wang, Jie; Xu, Lin; Liu, Tongyan; Yin, Rong Journal: Cancer communications Issue: Volume 41:Issue 7(2021) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗